Predictive biomarkers for adjuvant capecitabine benefit in early stage triple negative breast cancer in the FinXX clinical trial
| Image |  |
|---|---|
| Description | scientific article published on 31 January 2020 |
| Author/s | |
| Publication date | January 31, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |